Norbert W. Bischofberger - Nov 15, 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
President & CEO, Director
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Stock symbol
KRON
Transactions as of
Nov 15, 2023
Transactions value $
$1,470,395
Form type
4
Date filed
11/17/2023, 05:41 PM
Previous filing
Jun 2, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Purchase $1.1M +1.37M +169.3% $0.80 2.18M Nov 15, 2023 Direct F1
transaction KRON Common Stock Purchase $262K +262K +12.04% $1.00 2.44M Nov 16, 2023 Direct F2
transaction KRON Common Stock Purchase $106K +97.9K +4.01% $1.08 2.54M Nov 17, 2023 Direct F3
holding KRON Common Stock 4.37M Nov 15, 2023 See footnote F4
holding KRON Common Stock 264K Nov 15, 2023 See footnote F5
holding KRON Common Stock 264K Nov 15, 2023 See footnote F6
holding KRON Common Stock 264K Nov 15, 2023 See footnote F7
holding KRON Common Stock 264K Nov 15, 2023 See footnote F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $0.8045, and the range of prices were between $0.765 and $0.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 The weighted average purchase price for the transaction reported was $0.9965, and the range of prices were between $0.90 and $1.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F3 The weighted average purchase price for the transaction reported was $1.084, and the range of prices were between $1.04 and $1.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F4 By the Norbert W. & Inger A. Bischofberger Revocable Inter Vivos Trust, dtd August 29, 1994.
F5 By the Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The David Michael Anthony Dynasty GST Exempt Trust dated April 29, 2020.
F6 By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The David Michael Anthony Dynasty GST Non-Exempt Trust dated April 29, 2020
F7 By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The Irene Alisha Bischofberger Dynasty GST Exempt Trust dated April 29, 2020.
F8 By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The Irene Alisha Bischofberger Dynasty GST Non-Exempt Trust dated April 29, 2020